Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immuno-Vax is a small private healthcare consulting company focused on vaccine and biologics development rather than a traditional therapeutics pipeline company. Publicly available references identify Immuno-Vax, LLC as the consulting vehicle of Peter A. Patriarca, a former FDA and CDC official with deep expertise in regulatory affairs, clinical development, and vaccine policy. The firm appears to provide technical and regulatory consulting services across vaccine and other biologics programs, including support for INDs, BLAs, and broader development strategy. Based on the available information, Immuno-Vax does not appear to operate as a venture-backed drug developer with a disclosed internal pipeline, platform, or commercial product portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immuno-Vax.